Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States... Show more
Equifax shares entered the fall under pressure, sliding from a late-August peak near $194 to a trough around $137 by the end of September as rising mortgage rates cooled housing-related demand. October brought a recovery, capped by a sharp intraday gain of more than 10% following the company's third-quarter earnings report. The rebound reflected better-than-expected profitability and cost discipline rather than a turn in the underlying mortgage cycle.
The stock's behavior mirrors broader sector sentiment, where credit-data providers remain caught between resilient diversified, non-mortgage revenue and persistent softness in mortgage origination and refinancing. Analyst views have diverged accordingly, with one firm lowering its price target while maintaining an Outperform rating and another downgrading the shares to Perform on mortgage-related concerns.
Equifax is one of the three major U.S. consumer credit reporting agencies, operating alongside TransUnion (TRU) and Experian. The company supplies credit reports, credit scores, identity verification, fraud-prevention, and analytics services to lenders, insurers, employers, and government agencies across three reportable segments: Workforce Solutions, U.S. Information Solutions (USIS), and International.
Its competitive strengths include proprietary data assets such as The Work Number income and employment database, deep relationships across the financial-services and mortgage industries, and a co-ownership stake in the VantageScore credit-scoring model. Investors follow the stock closely because its results act as a barometer for consumer credit, housing, and labor-market activity, with mortgage-related revenue historically a meaningful swing factor.
Third-quarter 2026 results, released in October, showed adjusted EPS of $2.26, up 11% year over year and above consensus, while revenue of $1.69 billion grew about 10% on a reported basis. Net income rose to $211.7 million, with diluted EPS up 39% to $1.79. Diversified Markets revenue increased 8%, and U.S. mortgage revenue climbed 15% even as the broader mortgage market weakened late in the quarter.
The company simultaneously lowered its full-year revenue outlook to a range of $6.65 billion to $6.68 billion, from $6.71 billion to $6.78 billion, citing a sharp late-quarter drop in U.S. mortgage demand that management expects to persist. Fourth-quarter revenue guidance of $1.61 billion to $1.64 billion came in below analyst forecasts. Offsetting this, Equifax raised its full-year ex-FICO EBITDA margin growth target and pointed to a $150 million multi-year AI-driven operational-savings program, along with $550 million in year-to-date government contract value supporting income-verification services for programs such as SNAP and Medicaid.
Regulatory and product momentum also featured, including the FHFA's accelerated use of VantageScore for conforming mortgages and rapid lender adoption of VantageScore 4.0. Sentiment around the shares remained mixed, however, with Fair Isaac (FICO) royalty dynamics and a potential restructuring of tri-merge credit-report requirements among the factors analysts flagged as longer-term considerations.
Tickeron's Trending AI Robots page presents a curated selection of the platform's most relevant automated trading strategies. While Tickeron offers hundreds of AI trading bots that collectively monitor thousands of tickers, only the top-performing and most pertinent bots are surfaced in this section, helping traders filter a broad universe of signals down to the most notable ones. The bots vary widely in strategy, timeframe, and performance metrics, so the page serves as a starting point for evaluating systematic approaches rather than a one-size-fits-all recommendation. Investors interested in data-driven, automated strategies can explore the current selections on the Trending AI Robots page.
Looking ahead, the trajectory of U.S. mortgage rates and housing demand remains the most significant near-term variable for Equifax, with management flagging continued weakness into 2027. Investors will also monitor the ramp of newly signed government contracts, which are expected to benefit the Workforce Solutions segment as the calendar turns, and the shift of mortgage lenders toward the paid VantageScore model, a potential margin tailwind as adoption scales.
AI-driven productivity is another key theme, as cost-savings initiatives support margin expansion even amid softer revenue. Broader risks include elevated interest rates, a slowing consumer-credit cycle, and regulatory developments affecting credit-reporting and scoring practices. With full-year adjusted EPS guided to roughly $8.50 at the midpoint, the balance between mortgage headwinds and diversification benefits will likely define how the stock performs through the remainder of the year.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
EFX saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In 55 of the 79 cases, the stock moved further down in the following days. The odds of a decline are at 70%.
The 10-day RSI Indicator for EFX moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 18 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Moving Average Convergence Divergence Histogram (MACD) for EFX turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
EFX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EFX crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +1.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFX advanced for three days, in 202 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
EFX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 132 of 224 cases where EFX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. EFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.085) is normal, around the industry mean (13.131). P/E Ratio (33.087) is within average values for comparable stocks, (49.500). Projected Growth (PEG Ratio) (1.221) is also within normal values, averaging (2.814). Dividend Yield (0.012) settles around the average of (0.026) among similar stocks. P/S Ratio (3.088) is also within normal values, averaging (26.240).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of information solutions and human resources business process outsourcing services
Industry DataProcessingServices